rospedРоссийский педиатрический журнал имени М.Я. СтуденикинаM.Ya. Studenikin Russian Pediatric JournalФГАУ «НМИЦ здоровья детей» Минздрава России10.46563/1560-9561-2023-26-2-134-139zuwscgrosped-24Research ArticleОБЗОРЫREVIEWSЗначение эхокардиографии в инструментальной диагностике лёгочной гипертензии у детей с бронхолёгочной дисплазиейThe importance of echocardiography in the instrumental diagnosis of pulmonary hypertension in children with bronchopulmonary dysplasiaБасаргинаМилана АлександровнаBasarginaMilana A.

Канд. мед. наук, ст. науч. сотр. лаб. неонатологии и проблем здоровья раннего детского возраста; зав. отд-нием патологии новорождённых и детей раннего детского возраста ФГАУ «НМИЦ здоровья детей» Минздрава России

e-mail: milanablu@mail.ru

MD, PhD, senior researcher at the Laboratory of neonatology and early childhood health problems, Head of the Department of pathology of newborns and young children of the National Medical Research Center for Children’s Health, Moscow, 119991, Russian Federation

e-mail: milanablu@mail.ru

milanablu@mail.ruДавыдоваИрина ВладимировнаDavydovaIrina V.

Доктор мед. наук, зав. лаб. неонатологии и проблем здоровья раннего детского возраста ФГАУ «НМИЦ здоровья детей» Минздрава России

e-mail: davydova@nczd.ru

davydova@nczd.ruТуркоХиба РадвановнаTurkoKhiba R.

Врач ультразвуковой диагностики отд-ния ультразвуковой диагностики ФГАУ «НМИЦ здоровья детей» Мин­здрава России

e-mail: hiba.turko@gmail.com

hiba.turko@gmail.comБондарьВалерия АлександровнаBondarValeriya A.

Канд. мед. наук, науч. сотр., ФГАУ «НМИЦ здоровья детей» Минздрава России

e-mail: bondva23@gmail.com

bondva23@gmail.comФисенкоАндрей ПетровичFisenkoAndrey P.

Доктор мед. наук, проф., Заслуженный врач РФ, директор ФГАУ «НМИЦ здоровья детей» Минздрава России

e-mail: director@nczd.ru

director@nczd.ruСеливерстоваАлина АнатольевнаSeliverstovaAlina A.

Врач-неонатолог, отд-ние патологии новорожденных детей, мл. науч. сотр. лаб. неонатологии и проблем здоровья раннего детского возраста ФГАУ «НМИЦ здоровья детей» Минздрава России

e-mail: seliverstova_aa@mail.ru

seliverstova_aa@mail.ruФГАУ «Национальный медицинский исследовательский центр здоровья детей» Минздрава РоссииNational Medical Research Center for Children’s Health202309082023232134139Copyright © Басаргина М.А., Давыдова И.В., Турко Х.Р., Бондарь В.А., Фисенко А.П., Селиверстова А.А., 20232023Басаргина М.А., Давыдова И.В., Турко Х.Р., Бондарь В.А., Фисенко А.П., Селиверстова А.А.Basargina M.A., Davydova I.V., Turko K.R., Bondar V.A., Fisenko A.P., Seliverstova A.A.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://www.rosped.ru/jour/article/view/24

Раннее выявление грозного осложнения бронхолёгочной дисплазии (БЛД) — лёгочной гипертензии (ЛГ) — актуальная проблема педиатрии. Самым доступным инструментальным неинвазивным методом определения давления в лёгочной артерии является эхокардиография. Нарушения альвеологенеза и ангиогенеза сосудов малого круга кровообращения у недоношенных детей, формирующих БЛД, требуют тщательного эхокардиографического контроля с использованием дополнительного анализа изменений систолического индекса эксцентричности как надёжного маркёра ЛГ у детей с БЛД. Для повышения информативности следует также расширить использование данных эхокардиографии в сочетании с анализом содержания в крови натрийуретического пептида типа В или N-терминального конца предшественника натрийуретического пептида типа В.

Участие авторов

Участие авторов:Басаргина М.А., Давыдова И.В. — концепция и дизайн исследования, написание текста;Басаргина М.А., Турко Х.Р., Селиверстова А.А., Бондарь В.А. — сбор и обработка данных;Фисенко А.П. — редактирование.Все соавторы — утверждение окончательного варианта статьи, ответственность за целостность всех частей статьи.

Финансирование

Финансирование. Исследование не имело финансовой поддержки.

Конфликт интересов

Конфликт интересов. Авторы заявляют об отсутствии конфликта интересов. 

Поступила 17

Поступила 17.02.2023Принята к печати 21.03.2023Опубликована 28.04.2023

Early detection of such a formidable complication of bronchopulmonary dysplasia (BPD) as pulmonary hypertension (PH) is an urgent problem in pediatrics. Echocardiography is currently recognized as the most accessible and non-invasive method for determining pressure in the pulmonary artery. Disorders of alveogenesis and angiogenesis of the vessels of the small circulatory circle in premature infants forming BPD require careful echocardiographic control with using additional analysis of changes in the systolic eccentricity index (EI) as a reliable marker of PH in BPD infants. To increase the information content, it is also necessary to expand the use of EchoCG data in combination with analysis of the blood content of B type natriuretic peptide or the N-terminal pro-B-type natriuretic peptide.

Contribution

Contribution:Basargina M.A., Davydova I.V. — concept and design of the study;Basargina M.A., Turko Kh.R., Seli­verstova A.A., Bondar V.A. — data collection and processing;Basargina M.A., Davydova I.V. — writing the text;Fisenko A.P. — editing.All co-authors — approval of the final version of the article, responsibility for the integrity of all parts of the article.

Acknowledgment

Acknowledgment. The study had no sponsorship.

Conflict of interest

Conflict of interest. The authors declare no conflict of interest.

Received

Received: February 17, 2023Accepted: March 21, 2023Published: April 28, 2023

бронхолёгочная дисплазиялёгочная гипертензияэхокардиографияангиогенез сосудов малого круга кровообращенияальвеологенезbronchopulmonary dysplasiapulmonary hypertensionechocardiographyangiogenesis of the vessels of the pulmonary circulationalveologenesisReferencesRoyal College of Paediatrics and Child Health (RCPCH). National Neonatal Audit Programme (NNAP) 2020 Annual Report on 2019 Data. London; 2020.Royal College of Paediatrics and Child Health (RCPCH). National Neonatal Audit Programme (NNAP) 2020 Annual Report on 2019 Data. London; 2020.Jensen E.A., Edwards E.M., Greenberg L.T., Soll R.F., Ehret D.E., Horbar J.D. Severity of bronchopulmonary dysplasia among very preterm infants in the United States. Pediatrics. 2021; 148(1): 2020030007. https://doi.org/10.1542/peds.2020-030007Jensen E.A., Edwards E.M., Greenberg L.T., Soll R.F., Ehret D.E., Horbar J.D. Severity of bronchopulmonary dysplasia among very preterm infants in the United States. Pediatrics. 2021; 148(1): 2020030007. https://doi.org/10.1542/peds.2020-030007Khemani E., McElhinney D.B., Rhein L., Andrade O., Lacro R.V., Thomas K.C., et al. Pulmonary artery hypertension informally premature infants with bronchopulmonary dysplasia: clinical features and outcomes in the surfactant era. Pediatrics. 2007; 120(6): 1260–9. https://doi.org/10.1542/peds.2007-0971Khemani E., McElhinney D.B., Rhein L., Andrade O., Lacro R.V., Thomas K.C., et al. Pulmonary artery hypertension informally premature infants with bronchopulmonary dysplasia: clinical features and outcomes in the surfactant era. Pediatrics. 2007; 120(6): 1260–9. https://doi.org/10.1542/peds.2007-0971Ali Z., Schmidt P., Dodd J., Jeppesen D.L. Predictors of bronchopulmonary dysplasia and pulmonary hypertension in newborn children. Dan. Med. J. 2013; 60(8): A4688.Ali Z., Schmidt P., Dodd J., Jeppesen D.L. Predictors of bronchopulmonary dysplasia and pulmonary hypertension in newborn children. Dan. Med. J. 2013; 60(8): A4688.del Cerro M.J., Sabaté Rotés A., Cartón A., Deiros L., Bret M., Cordeiro M., et al. Pulmonary hypertension in bronchopulmonary dysplasia: clinical findings, cardiovascular anomalies and outcomes. Pediatr. Pulmonol. 2014; 49(1): 49–59. https://doi.org/10.1002/ppul.22797del Cerro M.J., Sabaté Rotés A., Cartón A., Deiros L., Bret M., Cordeiro M., et al. Pulmonary hypertension in bronchopulmonary dysplasia: clinical findings, cardiovascular anomalies and outcomes. Pediatr. Pulmonol. 2014; 49(1): 49–59. https://doi.org/10.1002/ppul.22797Nakanishi H., Uchiyama A., Kusuda S. Impact of pulmonary hypertension on neurodevelopmental outcome in preterm infants with bronchopulmonary dysplasia: a cohort study. J. Perinatol. 2016; 36(10): 890–6. https://doi.org/10.1038/jp.2016.108Nakanishi H., Uchiyama A., Kusuda S. Impact of pulmonary hypertension on neurodevelopmental outcome in preterm infants with bronchopulmonary dysplasia: a cohort study. J. Perinatol. 2016; 36(10): 890–6. https://doi.org/10.1038/jp.2016.108Bui C.B., Pang M.A., Sehgal A., Theda C., Lao J.C., Berger P.J., et al. Pulmonary hypertension associated with bronchopulmonary dysplasia in preterm infants. J. Reprod. Immunol. 2017; (124): 21–9. https://doi.org/10.1016/j.jri.2017.09.013Bui C.B., Pang M.A., Sehgal A., Theda C., Lao J.C., Berger P.J., et al. Pulmonary hypertension associated with bronchopulmonary dysplasia in preterm infants. J. Reprod. Immunol. 2017; (124): 21–9. https://doi.org/10.1016/j.jri.2017.09.013Arjaans S., Zwart E.A.H., Ploegstra M.J., Bos A.F., Kooi E.M.W., Hillege H.L., et al. Identification of gaps in the current knowledge on pulmonary hypertension in extremely preterm infants: a systematic review and meta-analysis. Paediatr. Perinat. Epidemiol. 2018; 32(3): 258–67. https://doi.org/10.1111/ppe.12444Arjaans S., Zwart E.A.H., Ploegstra M.J., Bos A.F., Kooi E.M.W., Hillege H.L., et al. Identification of gaps in the current knowledge on pulmonary hypertension in extremely preterm infants: a systematic review and meta-analysis. Paediatr. Perinat. Epidemiol. 2018; 32(3): 258–67. https://doi.org/10.1111/ppe.12444Nagiub M., Kanaan U., Simon D., Guglani L. Risk factors for development of pulmonary hypertension in infants with bronchopulmonary dysplasia: systematic review and meta-analysis. Paediatr. Respir. Rev. 2017; 23(1): 27–32. https://doi.org/10.1016/j.prrv.2016.11.003Nagiub M., Kanaan U., Simon D., Guglani L. Risk factors for development of pulmonary hypertension in infants with bronchopulmonary dysplasia: systematic review and meta-analysis. Paediatr. Respir. Rev. 2017; 23(1): 27–32. https://doi.org/10.1016/j.prrv.2016.11.003Galiè N., McLaughlin V.V., Rubin L.J., Simonneau G. An overview of the 6th World Symposium on Pulmonary Hypertension. Eur. Respir. J. 2019; 53(1): 1802148. https://doi.org/10.1183/13993003.02148-2018Galiè N., McLaughlin V.V., Rubin L.J., Simonneau G. An overview of the 6th World Symposium on Pulmonary Hypertension. Eur. Respir. J. 2019; 53(1): 1802148. https://doi.org/10.1183/13993003.02148-2018Wu K.Y., Jensen E.A., White A.M., Wang Y., Biko D.M., Nilan K., et al. Characterization of disease phenotype in very preterm infants with severe bronchopulmonary dysplasia. Am. J. Respir. Crit. Care Med. 2020; 201(11): 1398–406. https://doi.org/10.1164/rccm.201907-1342OCWu K.Y., Jensen E.A., White A.M., Wang Y., Biko D.M., Nilan K., et al. Characterization of disease phenotype in very preterm infants with severe bronchopulmonary dysplasia. Am. J. Respir. Crit. Care Med. 2020; 201(11): 1398–406. https://doi.org/10.1164/rccm.201907-1342OCLevy P.T., Jain A., Nawaytou H., Teitel D., Keller R., Fineman J., et al. Risk assessment and monitoring of chronic pulmonary hypertension in premature infants. J. Pediatr. 2020; 217: 199-209.e4. https://doi.org/10.1016/j.jpeds.2019.10.034Levy P.T., Jain A., Nawaytou H., Teitel D., Keller R., Fineman J., et al. Risk assessment and monitoring of chronic pulmonary hypertension in premature infants. J. Pediatr. 2020; 217: 199-209.e4. https://doi.org/10.1016/j.jpeds.2019.10.034Levy P.T., Levin J., Leeman K.T., Mullen M.P., Hansmann G., Kourembanas S. Diagnosis and management of pulmonary hypertension in infants with bronchopulmonary dysplasia. Semin. Fetal Neonatal Med. 2022: 27(4): 101351. https://doi.org/10.1016/j.siny.2022.101351Levy P.T., Levin J., Leeman K.T., Mullen M.P., Hansmann G., Kourembanas S. Diagnosis and management of pulmonary hypertension in infants with bronchopulmonary dysplasia. Semin. Fetal Neonatal Med. 2022: 27(4): 101351. https://doi.org/10.1016/j.siny.2022.101351Hansmann G. Left ventricular diastolic dysfunction in pediatric pulmonary hypertension. Circ. Cardiovasc. Imaging. 2016: 9(9): 005527. https://doi.org/10.1161/circimaging.116.005527Hansmann G. Left ventricular diastolic dysfunction in pediatric pulmonary hypertension. Circ. Cardiovasc. Imaging. 2016: 9(9): 005527. https://doi.org/10.1161/circimaging.116.005527El-Khuffash A., McNamara P.J. Hemodynamic assessment and monitoring of premature infants. Clin. Perinatol. 2017: 44(2): 377–93. https://doi.org/10.1016/j.clp.2017.02.001El-Khuffash A., McNamara P.J. Hemodynamic assessment and monitoring of premature infants. Clin. Perinatol. 2017: 44(2): 377–93. https://doi.org/10.1016/j.clp.2017.02.001Дворяковский И.В., Труханов А.И., Дворяковская Г.М., Смирнов И.Е. Ультразвуковая диагностика в педиатрии: история и достижения. Российский педиатрический журнал. 2022; 25(1): 66–72. https://doi.org/10.46563/1560-9561-2022-25-1-66-72 https://elibrary.ru/exnbocDvoryakovskiy I.V., Trukhanov A.I., Dvoryakovskaya G.M., Smirnov I.E. Ultrasound diagnostics in pediatrics: history and achievements. Rossiyskiy pediatricheskiy zhurnal. 2022; 25(1): 66–72. https://doi.org/10.46563/1560-9561-2022-25-1-66-72 https://elibrary.ru/exnboc (in Russian)Altit G., Dancea A., Renaud C., Perreault T., Lands L.C., Sant’Anna G. Pathophysiology, screening and diagnosis of pulmonary hypertension in infants with bronchopulmonary dysplasia - A review of the literature. Paediatr. Respir. Rev. 2017; 23(1): 16–26. https://doi.org/10.1016/j.prrv.2016.11.002Altit G., Dancea A., Renaud C., Perreault T., Lands L.C., Sant’Anna G. Pathophysiology, screening and diagnosis of pulmonary hypertension in infants with bronchopulmonary dysplasia - A review of the literature. Paediatr. Respir. Rev. 2017; 23(1): 16–26. https://doi.org/10.1016/j.prrv.2016.11.002Mourani P.M., Sontag M.K., Younoszai A., Ivy D.D., Abman S.H. Clinical utility of echocardiography for the diagnosis and management of pulmonary vascular disease in young children with chronic lung disease. Pediatrics. 2008; 121(2): 317–25. https://doi.org/10.1542/peds.2007-1583Mourani P.M., Sontag M.K., Younoszai A., Ivy D.D., Abman S.H. Clinical utility of echocardiography for the diagnosis and management of pulmonary vascular disease in young children with chronic lung disease. Pediatrics. 2008; 121(2): 317–25. https://doi.org/10.1542/peds.2007-1583Бондарь В.А., Давыдова И.В., Басаргина М.А., Фисенко А.П., Пушков А.А., Жанин И.С. и др. Роль генетических предикторов в доклинической диагностике бронхолегочной дисплазии. Кремлевская медицина. 2022; (1): 5–9. https://doi.org/10.26269/m7zs-qa37 https://elibrary.ru/qsdtsvBondar’ V.A., Davydova I.V., Basargina M.A., Fisenko A.P., Pushkov A.A., Zhanin I.S., et al. The role of genetic predictors in preclinical diagnostics of bronchopulmonary dysplasia. Kremlevskaya meditsina. 2022; (1): 5–9. https://doi.org/10.26269/m7zs-qa37 https://elibrary.ru/qsdtsv (in Russian)Kuiper E.J., Roestenberg P., Ehlken C., Lambert V., van Treslong-de Groot H.B., Lyons K.M., et al. Angiogenesis is not impaired in connective tissue growth factor (CTGF) knock-out mice. J. Histochem. Cytochem. 2007; 55(11): 1139–47. https://doi.org/10.1369/jhc.7A7258.2007Kuiper E.J., Roestenberg P., Ehlken C., Lambert V., van Treslong-de Groot H.B., Lyons K.M., et al. Angiogenesis is not impaired in connective tissue growth factor (CTGF) knock-out mice. J. Histochem. Cytochem. 2007; 55(11): 1139–47. https://doi.org/10.1369/jhc.7A7258.2007Chen S., Rong M., Platteau A., Hehre D., Smith H., Ruiz P., et al. CTGF disrupts alveolarization and induces pulmonary hypertension in neonatal mice: implication in the pathogenesis of severe bronchopulmonary dysplasia. Am. J. Physiol. Lung Cell Mol. Physiol. 2011; 300(3): 330–40. https://doi.org/10.1152/ajplung.00270.2010Chen S., Rong M., Platteau A., Hehre D., Smith H., Ruiz P., et al. CTGF disrupts alveolarization and induces pulmonary hypertension in neonatal mice: implication in the pathogenesis of severe bronchopulmonary dysplasia. Am. J. Physiol. Lung Cell Mol. Physiol. 2011; 300(3): 330–40. https://doi.org/10.1152/ajplung.00270.2010Селиверстова А.А., Давыдова И.В., Басаргина М.А., Фисенко А.П., Семикина Е.Л. Механизмы развития легочной гипертензии у детей с бронхолегочной дисплазией. Доктор.Ру. 2022; 21(7): 6–11. https://doi.org/10.31550/1727-2378-2022-21-7-6-11 https://elibrary.ru/lllqscSeliverstova A.A., Davydova I.V., Basargina M.A., Fisenko A.P., Semikina E.L. Mechanisms of development of pulmonary hypertension in children with bronchopulmonary dysplasia. Doktor.Ru. 2022; 21(7): 6–11. https://doi.org/10.31550/1727-2378-2022-21-7-6-11 https://elibrary.ru/lllqsc (in Russian)Abman S.H., Hansmann G., Archer S.L., Ivy D.D., Adatia I., Chung W.K., et al. Pediatric pulmonary hypertension: guidelines from the American Heart Association and American Thoracic Society. Circulation. 2015; 132(21): 2037–99. https://doi.org/10.1161/CIR.0000000000000329Abman S.H., Hansmann G., Archer S.L., Ivy D.D., Adatia I., Chung W.K., et al. Pediatric pulmonary hypertension: guidelines from the American Heart Association and American Thoracic Society. Circulation. 2015; 132(21): 2037–99. https://doi.org/10.1161/CIR.0000000000000329Krishnan U., Feinstein J.A., Adatia I., Austin E.D., Mullen M.P., Hopper R.K., et al. Evaluation and management of pulmonary hypertension in children with bronchopulmonary dysplasia. J. Pediatr. 2017; 188: 24–34. https://doi.org/10.1016/j.jpeds.2017.05.029Krishnan U., Feinstein J.A., Adatia I., Austin E.D., Mullen M.P., Hopper R.K., et al. Evaluation and management of pulmonary hypertension in children with bronchopulmonary dysplasia. J. Pediatr. 2017; 188: 24–34. https://doi.org/10.1016/j.jpeds.2017.05.029Hansmann G., Sallmon H., Roehr C.C., Kourembanas S., Austin E.D., Koestenberger M., et al. Pulmonary hypertension in bronchopulmonary dysplasia. Pediatr. Res. 2021; 89(3): 446–55. https://doi.org/10.1038/s41390-020-0993-4Hansmann G., Sallmon H., Roehr C.C., Kourembanas S., Austin E.D., Koestenberger M., et al. Pulmonary hypertension in bronchopulmonary dysplasia. Pediatr. Res. 2021; 89(3): 446–55. https://doi.org/10.1038/s41390-020-0993-4O’Byrne M.L., Kennedy K.F., Kanter J.P., Berger J.T., Glatz A.C. Risk factors for major early adverse events related to cardiac catheterization in children and young adults with pulmonary hypertension: An analysis of data from the IMPACT (Improving Adult and Congenital Treatment) Registry. J. Am. Heart Assoc. 2018; 7(5): 008142. https://doi.org/10.1161/ JAHA.117.008142O’Byrne M.L., Kennedy K.F., Kanter J.P., Berger J.T., Glatz A.C. Risk factors for major early adverse events related to cardiac catheterization in children and young adults with pulmonary hypertension: An analysis of data from the IMPACT (Improving Adult and Congenital Treatment) Registry. J. Am. Heart Assoc. 2018; 7(5): 008142. https://doi.org/10.1161/ JAHA.117.008142O’Byrne M.L., Glatz A.C., Hanna B.D., Shinohara R.T., Gillespie M.J., Dori Y., et al. Predictors of catastrophic adverse outcomes in children with pulmonary hypertension undergoing cardiac catheterization: a multi-institutional analysis from the pediatric health information systems database. J. Am. Coll. Cardiol. 2015; 66(11): 1261–9. https://doi.org/10.1016/j.jacc.2015.07.032O’Byrne M.L., Glatz A.C., Hanna B.D., Shinohara R.T., Gillespie M.J., Dori Y., et al. Predictors of catastrophic adverse outcomes in children with pulmonary hypertension undergoing cardiac catheterization: a multi-institutional analysis from the pediatric health information systems database. J. Am. Coll. Cardiol. 2015; 66(11): 1261–9. https://doi.org/10.1016/j.jacc.2015.07.032Овсянников Д.Ю., Дегтярёва Е.А., Мирошниченко В.П., Стрельникова В.А., Абрамян М.А. Факторы риска, диагностика, скрининг и терапия легочной гипертензии у детей с бронхолегочной дисплазией. Доктор.Ру. 2022; 21(7): 12–9. https://doi.org/10.31550/1727-23782022-21-7-12-19 https://elibrary.ru/jyywntOvsyannikov D.Yu., Degtyareva E.A., Miroshnichenko V.P., Strel’nikova V.A., Abramyan M.A. Risk factors, diagnosis, screening and therapy of pulmonary hypertension in children with bronchopulmonary dysplasia. Doktor.Ru. 2022; 21(7): 12–9. https://doi.org/10.31550/1727-23782022-21-7-12-19 https://elibrary.ru/jyywnt (in Russian)Malloy K.W., Austin E.D. Pulmonary hypertension in the child with bronchopulmonary dysplasia. Pediatr. Pulmonol. 2021; 56(11): 3546–56. https://doi.org/10.1002/ppul.25602Malloy K.W., Austin E.D. Pulmonary hypertension in the child with bronchopulmonary dysplasia. Pediatr. Pulmonol. 2021; 56(11): 3546–56. https://doi.org/10.1002/ppul.25602Ruoss J.L., Rios D.R., Levy P.T. Updates on management for acute and chronic phenotypes of neonatal pulmonary hypertension. Clin. Perinatol. 2020; 47(3): 593–615. https://doi.org/10.1016/j.clp.2020.05.006Ruoss J.L., Rios D.R., Levy P.T. Updates on management for acute and chronic phenotypes of neonatal pulmonary hypertension. Clin. Perinatol. 2020; 47(3): 593–615. https://doi.org/10.1016/j.clp.2020.05.006Augustine D.X., Coates-Bradshaw L.D., Willis J., Harkness A., Ring L., Grapsa J., et al. Echocardiographic assessment of pulmonary hypertension: a guideline protocol from the British Society of Echocardiography. Echo Res. Pract. 2018; 5(3): G11–24. https://doi.org/10.1530/ERP-17-0071Augustine D.X., Coates-Bradshaw L.D., Willis J., Harkness A., Ring L., Grapsa J., et al. Echocardiographic assessment of pulmonary hypertension: a guideline protocol from the British Society of Echocardiography. Echo Res. Pract. 2018; 5(3): G11–24. https://doi.org/10.1530/ERP-17-0071Humbert M., Kovacs G., Hoeper M.M., Badagliacca R., Berger R.M.F., Brida M., et al. 2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension. Eur. Heart J. 2022; 61(1): 2200879. https://doi.org/10.1183/13993003.00879-2022Humbert M., Kovacs G., Hoeper M.M., Badagliacca R., Berger R.M.F., Brida M., et al. 2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension. Eur. Heart J. 2022; 61(1): 2200879. https://doi.org/10.1183/13993003.00879-2022Bitar E., Lalitha R., Kumaran K., Yaskina M., Hyderi A. The value of early echocardiographic parameters to predict late pulmonary hypertension in extreme premature infants. Prog. Pediatr. Cardiol. 2021; 63(78): 101402. https://doi.org/10.1016/j.ppedcard.2021.101402Bitar E., Lalitha R., Kumaran K., Yaskina M., Hyderi A. The value of early echocardiographic parameters to predict late pulmonary hypertension in extreme premature infants. Prog. Pediatr. Cardiol. 2021; 63(78): 101402. https://doi.org/10.1016/j.ppedcard.2021.101402Parasuraman S., Walker S., Loudon B.L., Gollop N.D., Wilson A.M., Lowery C., et al. Assessment of pulmonary artery pressure by echocardiography – A comprehensive review. Int. J. Cardiol. Heart Vasc. 2016; 12: 45–51. https://doi.org/10.1016/j.ijcha.2016.05.011Parasuraman S., Walker S., Loudon B.L., Gollop N.D., Wilson A.M., Lowery C., et al. Assessment of pulmonary artery pressure by echocardiography – A comprehensive review. Int. J. Cardiol. Heart Vasc. 2016; 12: 45–51. https://doi.org/10.1016/j.ijcha.2016.05.011Wilson N., Reed K., Allen H.D., Marx G.R., Goldberg S.J. Doppler echocardiographic observations of pulmonary and transvalvular changes after birth and early neonatal period. Am. Heart J. 1987; 113(3): 750–8. https://doi.org/10.1016/0002-8703(87)90716-2Wilson N., Reed K., Allen H.D., Marx G.R., Goldberg S.J. Doppler echocardiographic observations of pulmonary and transvalvular changes after birth and early neonatal period. Am. Heart J. 1987; 113(3): 750–8. https://doi.org/10.1016/0002-8703(87)90716-2Arjaans S., Fries M.W.F., Schoots M.H., Schilte C.F.M., Roofthooft M.T.R., Elianne J.L.E., et al. Clinical significance of early pulmonary hypertension in preterm infants. J. Pediatr. 2022; 251: 74–81.e3. https://doi.org/10.1016/j.jpeds.2022.07.039Arjaans S., Fries M.W.F., Schoots M.H., Schilte C.F.M., Roofthooft M.T.R., Elianne J.L.E., et al. Clinical significance of early pulmonary hypertension in preterm infants. J. Pediatr. 2022; 251: 74–81.e3. https://doi.org/10.1016/j.jpeds.2022.07.039Chaoui R., Taddei F., Rizzo G., Bast C., Lenz F., Bollmann R. Doppler echocardiography of the main stems of the pulmonary arteries in the normal human fetus. Ultrasound. Obstet. Gynecol. 1998; 11(3): 173–9. https://doi.org/10.1046/j.1469-0705.1998.11030173.xChaoui R., Taddei F., Rizzo G., Bast C., Lenz F., Bollmann R. Doppler echocardiography of the main stems of the pulmonary arteries in the normal human fetus. Ultrasound. Obstet. Gynecol. 1998; 11(3): 173–9. https://doi.org/10.1046/j.1469-0705.1998.11030173.xNagiub M., Lee S., Guglani L. Echocardiographic assessment of pulmonary hypertension in infants with bronchopulmonary dysplasia: systematic review of literature and a proposed algorithm for assessment. Echocardiography. 2015; 32(5): 819–33. https://doi.org/10.1111/echo.12738Nagiub M., Lee S., Guglani L. Echocardiographic assessment of pulmonary hypertension in infants with bronchopulmonary dysplasia: systematic review of literature and a proposed algorithm for assessment. Echocardiography. 2015; 32(5): 819–33. https://doi.org/10.1111/echo.12738Singh A., Feingold B., Rivera-Lebron B., Weiner D., Drant S. Correlating objective echocardiographic parameters in patients with pulmonary hypertension due to bronchopulmonary dysplasia. J. Perinatol. 2019; 39(9): 1282–90. https://doi.org/10.1038/s41372-019-0429-3Singh A., Feingold B., Rivera-Lebron B., Weiner D., Drant S. Correlating objective echocardiographic parameters in patients with pulmonary hypertension due to bronchopulmonary dysplasia. J. Perinatol. 2019; 39(9): 1282–90. https://doi.org/10.1038/s41372-019-0429-3Басаргина М.А., Фисенко А.П., Давыдова И.В., Кондратьев М.В., Петрова А.С., Жарова О.П. и др. Клинико-функциональные особенности малого круга кровообращения у детей с новой формой бронхолёгочной дисплазии. Российский педиатрический журнал. 2021; 24(5): 292–9. https://doi.org/10.46563/1560-9561-2021-24-5-292-299 https://elibrary.ru/oymtnnBasargina M.A., Fisenko A.P, Davydova I.V., Kondrat’ev M.V., Petrova A.S., Zharova O.P., et al. Clinical and functional features of the small circle of blood circulation in children with a new form of bronchopulmonary dysplasia. Rossiyskiy pediatricheskiy zhurnal. 2021; 24(5): 292–9. https://doi.org/10.46563/1560-9561-2021-24-5-292-299 https://elibrary.ru/oymtnn (in Russian)

The authors declare that there are no conflicts of interest present.